A Clinical Trial Comparing Amrutastaka Churna and Abhayadi Churna in Patients with Acid Reflux (GERD DISEASE)

AN OPEN LABELLED RANDOMIZED CONTROLLED TRIAL TO COMPARE THE CLINICAL EFFECT OF AMRUTASTAKA CHURNA OVER ABHAYADI CHURNA IN URDWAGA AMLAPITTA VIS-A-VIS GASTROESOPHAGEAL REFLUX DISEASE - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111959

Enrollment

Registered

2026-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Amlapitta symptoms like Chardi,Utklesha, Avipaka ,Tikta-Amla Udgara, Hritkantadaha, Shirashoola, Aruchi will be included in the study. 2.Subjects with age group of 18 to 70 years and either gender will be included in the study. 3.Subjects who will sign for informed consent will be included in the study.

Exclusion criteria

Exclusion criteria: 1.Pregnant and Lactating Mother with feature of Urdwaga Amlapitta will be excluded from the study. 2.Subjects with history of Haematemesis, Malena and other systemic disorders will be excluded from the study. 3.Subjects associated with IBS, Psychiatry illness, Bleeding disorders will be excluded from the study. 4.Subjects suffering from Gastric carcinoma will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
TO COMPARE THE EFFECT OF AMRUTASTAKA CHURNA OVER ABHAYADI CHURNA IN URDWAGA AMLAPITTA VIS- -VIS GASTROESOPHAGEAL REFLUX DISEASE.Timepoint: Day 0 Day 15 Day 30 Day 37	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Janaki Y S

Taranath Government Ayurveda medical college and hospital, Bellary.

drjanakiys@gmail.com9741140053

Outcome results